Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Generic Line > Sun Recalls Nimodipine, Dampening Its Positive Manufacturing News

Generic Line

Sept. 12, 2012 | Vol. 29 No. 18

Sun Recalls Nimodipine, Dampening Its Positive Manufacturing News

Sun Pharmaceutical is recalling one lot of its 30-mg nimodipine after a customer complaint about possible crystallization of the solution inside the capsule.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

France Fines Sanofi $53M for Deterring Generic Plavix FDA Rejects Endo’s Petition to Deny Generics of Opana ER Sanofi Fined for Discouraging Generic Plavix Prescriptions Sanofi Fined for Discouraging Generic Plavix Prescriptions

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.